ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.

Kei Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.